207 related articles for article (PubMed ID: 22041057)
1. Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.
Sherer BA; Hull K; Green O; Basarab G; Hauck S; Hill P; Loch JT; Mullen G; Bist S; Bryant J; Boriack-Sjodin A; Read J; DeGrace N; Uria-Nickelsen M; Illingworth RN; Eakin AE
Bioorg Med Chem Lett; 2011 Dec; 21(24):7416-20. PubMed ID: 22041057
[TBL] [Abstract][Full Text] [Related]
2. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agents.
Eakin AE; Green O; Hales N; Walkup GK; Bist S; Singh A; Mullen G; Bryant J; Embrey K; Gao N; Breeze A; Timms D; Andrews B; Uria-Nickelsen M; Demeritt J; Loch JT; Hull K; Blodgett A; Illingworth RN; Prince B; Boriack-Sjodin PA; Hauck S; MacPherson LJ; Ni H; Sherer B
Antimicrob Agents Chemother; 2012 Mar; 56(3):1240-6. PubMed ID: 22183167
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
[TBL] [Abstract][Full Text] [Related]
6. Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.
Uria-Nickelsen M; Blodgett A; Kamp H; Eakin A; Sherer B; Green O
Int J Antimicrob Agents; 2013 Jan; 41(1):28-35. PubMed ID: 23142086
[TBL] [Abstract][Full Text] [Related]
7. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
Lübbers T; Angehrn P; Gmünder H; Herzig S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
[TBL] [Abstract][Full Text] [Related]
9. Leveraging structural information for the discovery of new drugs: computational methods.
Nguyen TB; Wong SE; Lightstone FC
Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
[TBL] [Abstract][Full Text] [Related]
10. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
[TBL] [Abstract][Full Text] [Related]
11. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
[TBL] [Abstract][Full Text] [Related]
13. In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
Brvar M; Perdih A; Hodnik V; Renko M; Anderluh G; Jerala R; Solmajer T
Bioorg Med Chem; 2012 Apr; 20(8):2572-80. PubMed ID: 22444877
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring.
Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Suzuki K; Ueda T; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem; 2004 Nov; 12(21):5515-24. PubMed ID: 15465328
[TBL] [Abstract][Full Text] [Related]
15. A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
Angehrn P; Goetschi E; Gmuender H; Hebeisen P; Hennig M; Kuhn B; Luebbers T; Reindl P; Ricklin F; Schmitt-Hoffmann A
J Med Chem; 2011 Apr; 54(7):2207-24. PubMed ID: 21388139
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
17. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
[TBL] [Abstract][Full Text] [Related]
18. Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
Basarab GS; Hill PJ; Garner CE; Hull K; Green O; Sherer BA; Dangel PB; Manchester JI; Bist S; Hauck S; Zhou F; Uria-Nickelsen M; Illingworth R; Alm R; Rooney M; Eakin AE
J Med Chem; 2014 Jul; 57(14):6060-82. PubMed ID: 24959892
[TBL] [Abstract][Full Text] [Related]
19. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
